Analysed ZEO SCIENTIFIX INC (ZEOX:OTCMKTS) News Sources
ZEO ScientifiX Surpasses 500 Physicians Trained in Regenerative Medicine Compliance; Monthly Masterclasses Average 70+ Clinicians
21-04-2026
yahoo.com
Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics--Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX
09-04-2026
yahoo.com
Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX (OTCQB:ZEOX)
09-04-2026
yahoo.com
ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage
07-04-2026
yahoo.com
Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's Allogeneic Stem Cell Therapy in the United States
07-01-2026
yahoo.com
ZEO ScientifiX Positions for National Growth as Stem Cell Market Opens in Florida
09-07-2025
yahoo.com
What is the current price of ZEO SCIENTIFIX INC (ZEOX:OTCMKTS)?
The current price of ZEO SCIENTIFIX INC (ZEOX:OTCMKTS) is $1.93.
ZEO SCIENTIFIX INC (ZEOX:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ZEO SCIENTIFIX INC (ZEOX:OTCMKTS) since the previous trading day is $0.03.
ZEO SCIENTIFIX INC (ZEOX:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ZEO SCIENTIFIX INC (ZEOX:OTCMKTS) since the previous trading day is 1.5789%.
What is the most recent average sentiment score for ZEO SCIENTIFIX INC (ZEOX:OTCMKTS)?
The most recent average sentiment score for ZEO SCIENTIFIX INC (ZEOX:OTCMKTS) is 85 out of 100.
What is the most recent average sentiment for ZEO SCIENTIFIX INC (ZEOX:OTCMKTS)?
The most recent sentiment for ZEO SCIENTIFIX INC (ZEOX:OTCMKTS) is .
SEC-8K** Filing Available For ZEO SCIENTIFIX INC (ZEOX:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.